Investors in Alibaba (BABA) have until Oct. 5 to seek lead plaintiff status in a securities fraud class action filed by Hagens Berman Sobol Shapiro LLP.
"We are investigating whether Alibaba executives intentionally concealed the company's regulatory ties and engaged in fraudulent operational practices to mislead the market about its true risk profile and competitive position," Reed Kathrein, the Hagens Berman partner leading the investigation, said.
The case, Wistisen v. Alibaba Group Holding Limited, et al., No. 1:26-cv-06654 (S.D.N.Y.), accuses Alibaba and certain executive officers of violating the Securities Exchange Act of 1934. The class period runs from June 26, 2025 through June 24, 2026. The complaint alleges defendants made false and misleading statements and failed to disclose adverse facts about the company's regulatory exposure, including undisclosed Chinese military ties and fraudulent AI distillation attacks. The truth regarding these issues was revealed through a series of partial corrective disclosures, according to the complaint, which removed artificial inflation from the stock price and caused investor losses.
Hagens Berman, which has secured more than $2.9 billion in securities litigation recoveries, is one of several firms pursuing claims against Alibaba. Rosen Law Firm, Pomerantz, Levi & Korsinsky, Bernstein Liebhard, and Robbins LLP have all issued investor alerts regarding the case, pointing to broad legal exposure for the company. The multiplicity of filings is typical in securities class actions, where multiple firms compete for lead plaintiff appointment.
Investors who purchased Alibaba securities during the class period and suffered substantial losses may request appointment as lead plaintiff by Oct. 5. Class members do not need to seek lead plaintiff status to share in any potential recovery. The firm can be reached at 844-916-0895 or [email protected]. Whistleblowers with non-public information about Alibaba may also be eligible for SEC rewards of up to 30 percent of any successful recovery.
The lawsuit follows a period of heightened regulatory scrutiny for Alibaba, which completed an HK$80 billion placing of new shares in Hong Kong on Aug. 26. The company's Qwen AI division also launched its Qwen3.8-Flash model the same week, as Alibaba competes with Baidu and Tencent in China's rapidly evolving AI market.
The litigation adds to near-term pressure on BABA shares, which have been volatile as the company navigates regulatory challenges and competitive dynamics in China's technology sector. The Oct. 5 deadline is the next key date for the stock, as lead plaintiff selection will shape how the case proceeds and the potential scope of damages. Investors holding BABA through the class period should monitor developments closely, as the outcome could affect the ADR's valuation.
This article is for informational purposes only and does not constitute investment advice.